BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lario M, Muñoz L, Ubeda M, Borrero MJ, Martínez J, Monserrat J, Díaz D, Alvarez-Mon M, Albillos A. Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis. J Hepatol 2013;59:723-30. [PMID: 23742913 DOI: 10.1016/j.jhep.2013.05.042] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Jeon D, Kim YJ, Kim S, Choi WM, Lee D, Shim JH, Kim KM, Lim YS, Lee HC, Choi J. Liver Cirrhosis Increases the Risk of Herpes Zoster: A Nationwide Population-Based Cohort Study. Am J Gastroenterol 2023. [PMID: 36746415 DOI: 10.14309/ajg.0000000000002209] [Reference Citation Analysis]
2 Zheng L, Lu Y, Wu J, Zheng M. Development and validation of a prognostic nomogram model for ICU patients with alcohol-associated cirrhosis. Dig Liver Dis 2023:S1590-8658(23)00159-7. [PMID: 36693767 DOI: 10.1016/j.dld.2023.01.148] [Reference Citation Analysis]
3 Schinas G, Polyzou E, Mitropetrou F, Pazionis A, Gogos C, Triantos C, Akinosoglou K. COVID-19 Vaccination in Patients with Chronic Liver Disease. Viruses 2022;14. [PMID: 36560782 DOI: 10.3390/v14122778] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Baïsse A, Daix T, Hernandez Padilla AC, Jeannet R, Barraud O, Dalmay F, François B, Vignon P, Lafon T. High prevalence of infections in non-COVID-19 patients admitted to the Emergency Department with severe lymphopenia. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07295-5] [Reference Citation Analysis]
5 Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, Álvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 2022;19:112-34. [PMID: 34703031 DOI: 10.1038/s41575-021-00520-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]
6 Mallik M, Singhai A, Khadanga S, Ingle V. The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis. Cureus 2022. [DOI: 10.7759/cureus.21226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Auma AWN, Shive CL, Kostadinova L, Anthony DD. Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection. Viruses 2021;14:50. [PMID: 35062255 DOI: 10.3390/v14010050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Auma AWN, Shive CL, Lange A, Damjanovska S, Kowal C, Zebrowski E, Pandiyan P, Wilson B, Kalayjian RC, Canaday DH, Anthony DD. Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons. Front Immunol 2021;12:641230. [PMID: 33912168 DOI: 10.3389/fimmu.2021.641230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Weiss E, de la Grange P, Defaye M, Lozano JJ, Aguilar F, Hegde P, Jolly A, Moga L, Sukriti S, Agarwal B, Gurm H, Tanguy M, Poisson J, Clària J, Abback PS, Périanin A, Mehta G, Jalan R, Francoz C, Rautou PE, Lotersztajn S, Arroyo V, Durand F, Moreau R. Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF. Front Immunol 2020;11:619039. [PMID: 33613548 DOI: 10.3389/fimmu.2020.619039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
10 Rueschenbaum S, Ciesek S, Queck A, Widera M, Schwarzkopf K, Brüne B, Welsch C, Wedemeyer H, Zeuzem S, Weigert A, Lange CM. Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure. Front Immunol 2020;11:534731. [PMID: 33574809 DOI: 10.3389/fimmu.2020.534731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
11 Bozward AG, Warricker F, Oo YH, Khakoo SI. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade. Front Immunol 2021;12:643310. [PMID: 33995362 DOI: 10.3389/fimmu.2021.643310] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
12 Lee DU, Fan GH, Hastie DJ, Prakasam VN, Addonizio EA, Ahern RR, Seog KJ, Karagozian R. The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data. J Clin Exp Hepatol 2021;11:531-43. [PMID: 34511813 DOI: 10.1016/j.jceh.2021.01.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
13 Nakamura A, Yoshimura T, Deguchi M, Hosokawa Y, Someya G, Satoh T, Ichikawa T, Okuyama K, Yosioka Y, Asakura H. The significance of measuring peripheral blood lymphocytosis in liver cirrhosis-Diagnosis of cirrhosis-associated immune dysfunction using hemogram. Acta hepatologica Japonica 2020;61:552-563. [DOI: 10.2957/kanzo.61.552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Lurje I, Hammerich L, Tacke F. Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer. Int J Mol Sci 2020;21:E7378. [PMID: 33036244 DOI: 10.3390/ijms21197378] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
15 Zadka Ł, Grybowski DJ, Dzięgiel P. Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance. Cell Oncol (Dordr) 2020;43:539-75. [PMID: 32488850 DOI: 10.1007/s13402-020-00519-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tsai HC, Hsu CF, Huang CC, Huang SF, Li TH, Yang YY, Lin MW, Lee TY, Liu CW, Huang YH, Hou MC, Lin HC. Propranolol Suppresses the T-Helper Cell Depletion-Related Immune Dysfunction in Cirrhotic Mice. Cells 2020;9:E604. [PMID: 32138352 DOI: 10.3390/cells9030604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
17 Lebossé F, Gudd C, Tunc E, Singanayagam A, Nathwani R, Triantafyllou E, Pop O, Kumar N, Mukherjee S, Hou TZ, Quaglia A, Zoulim F, Wendon J, Dhar A, Thursz M, Antoniades CG, Khamri W. CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction. EBioMedicine 2019;49:258-68. [PMID: 31678004 DOI: 10.1016/j.ebiom.2019.10.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Martin Mateos R, Albillos A. Sepsis in Patients With Cirrhosis Awaiting Liver Transplantation: New Trends and Management. Liver Transpl 2019;25:1700-9. [PMID: 31408581 DOI: 10.1002/lt.25621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Lebossé F, Gudd C, Tunc E, Singanayagam A, Nathwani R, Triantafyllou E, Pop O, Kumar N, Mukherjee S, Hou TZ, Quaglia A, Zoulim F, Wendon J, Dhar A, Thursz M, Antoniades CG, Khamri W. CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction. EBioMedicine 2019;49:258-68. [PMID: 31678004 DOI: 10.1016/j.ebiom.2019.10.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
20 Zhao J, Shi J, Qu M, Zhao X, Wang H, Huang M, Liu Z, Li Z, He Q, Zhang S, Zhang Z. Hyperactive Follicular Helper T Cells Contribute to Dysregulated Humoral Immunity in Patients With Liver Cirrhosis. Front Immunol 2019;10:1915. [PMID: 31456809 DOI: 10.3389/fimmu.2019.01915] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Martin-Mateos R, Alvarez-Mon M, Albillos A. Dysfunctional Immune Response in Acute-on-Chronic Liver Failure: It Takes Two to Tango. Front Immunol 2019;10:973. [PMID: 31118937 DOI: 10.3389/fimmu.2019.00973] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
22 Acharya C, Bajaj JS. Altered Microbiome in Patients With Cirrhosis and Complications. Clin Gastroenterol Hepatol 2019;17:307-21. [PMID: 30099098 DOI: 10.1016/j.cgh.2018.08.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 19.0] [Reference Citation Analysis]
23 Mohanraj BS, Rangnekar AS, Timpone JG. Infections in Liver Transplantation. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Rim CH, Kim HJ, Seong J. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Radiother Oncol. 2019;131:135-144. [PMID: 30773180 DOI: 10.1016/j.radonc.2018.12.005] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 15.6] [Reference Citation Analysis]
25 Tuchendler E, Tuchendler PK, Madej G. Immunodeficiency caused by cirrhosis. Clin Exp Hepatol 2018;4:158-64. [PMID: 30324140 DOI: 10.5114/ceh.2018.78119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
26 Ozeki I, Nakajima T, Suii H, Tatsumi R, Yamaguchi M, Kimura M, Arakawa T, Kuwata Y, Ohmura T, Hige S, Karino Y, Toyota J. Analysis of hepatitis B surface antigen (HBsAg) using high-sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays. Hepatol Res 2018;48:E263-74. [PMID: 28884879 DOI: 10.1111/hepr.12979] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
27 He C, Peng W, Li C, Wen TF. Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma. Medicine (Baltimore) 2017;96:e8540. [PMID: 29137062 DOI: 10.1097/MD.0000000000008540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
28 Gustot T, Fernandez J, Szabo G, Albillos A, Louvet A, Jalan R, Moreau R, Moreno C. Sepsis in alcohol-related liver disease. J Hepatol 2017;67:1031-50. [PMID: 28647569 DOI: 10.1016/j.jhep.2017.06.013] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 10.0] [Reference Citation Analysis]
29 Abdelhamid NM, Chen YC, Wang YC, Cheng CH, Wu TJ, Lee CF, Wu TH, Chou HS, Chan KM, Lee WC, Soong RS. Pre-Transplantation Immune Cell Distribution and Early Post-Transplant Fungal Infection Are the Main Risk Factors of Liver Transplantation Recipients in Lower Model of End-Stage Liver Disease. Transplant Proc 2017;49:92-7. [PMID: 28104167 DOI: 10.1016/j.transproceed.2016.11.014] [Reference Citation Analysis]
30 Weiner AA, Olsen J, Ma D, Dyk P, DeWees T, Myerson RJ, Parikh P. Stereotactic body radiotherapy for primary hepatic malignancies - Report of a phase I/II institutional study. Radiother Oncol 2016;121:79-85. [PMID: 27566894 DOI: 10.1016/j.radonc.2016.07.020] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 7.4] [Reference Citation Analysis]
31 Martín-mateos R, Mateos B, Lledó J, Téllez L, Albillos A. Infecciones bacterianas en la cirrosis. Medicine - Programa de Formación Médica Continuada Acreditado 2016;12:666-672. [DOI: 10.1016/j.med.2016.05.020] [Reference Citation Analysis]
32 Sun DP, Jin H, Ding CY, Liang JH, Wang L, Fan L, Wu YJ, Xu W, Li JY. Thymic hyperplasia after chemotherapy in adults with mature B cell lymphoma and its influence on thymic output and CD4(+) T cells repopulation. Oncoimmunology 2016;5:e1137417. [PMID: 27467956 DOI: 10.1080/2162402X.2015.1137417] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
33 Li Y, Han T. Mechanisms of susceptibility to bacterial infections in cirrhotic patients. Shijie Huaren Xiaohua Zazhi 2015; 23(22): 3560-3566 [DOI: 10.11569/wcjd.v23.i22.3560] [Reference Citation Analysis]
34 Heymann F, Peusquens J, Ludwig-Portugall I, Kohlhepp M, Ergen C, Niemietz P, Martin C, van Rooijen N, Ochando JC, Randolph GJ, Luedde T, Ginhoux F, Kurts C, Trautwein C, Tacke F. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology 2015;62:279-91. [PMID: 25810240 DOI: 10.1002/hep.27793] [Cited by in Crossref: 231] [Cited by in F6Publishing: 233] [Article Influence: 28.9] [Reference Citation Analysis]
35 Bernsmeier C, Singanayagam A, Patel VC, Wendon J, Antoniades CG. Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure. Immunotherapy. 2015;7:641-654. [PMID: 26065379 DOI: 10.2217/imt.15.27] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
36 Zheng Z, Lin B, Zhang J, Yang Z, Xie H, Zhou L, Zhang M, Zheng S. Absolute lymphocyte count recovery at 1 month after transplantation predicts favorable outcomes of patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2015;30:706-11. [PMID: 25238140 DOI: 10.1111/jgh.12782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
37 Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 2014;61:1385-96. [PMID: 25135860 DOI: 10.1016/j.jhep.2014.08.010] [Cited by in Crossref: 691] [Cited by in F6Publishing: 688] [Article Influence: 76.8] [Reference Citation Analysis]
38 Shmagel KV, Saidakova EV, Korolevskaya LB, Shmagel NG, Chereshnev VA, Anthony DD, Lederman MM. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART. AIDS 2014;28:2381-8. [PMID: 25111083 DOI: 10.1097/QAD.0000000000000418] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
39 Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, Gustot T, Bernardi M, Canton R, Albillos A, Lammert F, Wilmer A, Mookerjee R, Vila J, Garcia-Martinez R, Wendon J, Such J, Cordoba J, Sanyal A, Garcia-Tsao G, Arroyo V, Burroughs A, Ginès P. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014;60:1310-24. [PMID: 24530646 DOI: 10.1016/j.jhep.2014.01.024] [Cited by in Crossref: 568] [Cited by in F6Publishing: 604] [Article Influence: 63.1] [Reference Citation Analysis]
40 Nagai S, Abouljoud MS, Moonka D, Yoshida A. The authors' reply. Transplantation 2014;97:e33-4. [PMID: 24637871 DOI: 10.1097/TP.0000000000000035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20(10): 2542-2554 [PMID: 24627590 DOI: 10.3748/wjg.v20.i10.2542] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 89] [Article Influence: 9.6] [Reference Citation Analysis]